Dr. Reddy's Laboratories Statistics

Total Valuation

Dr. Reddy's Laboratories has a market cap or net worth of INR 1.11 trillion. The enterprise value is 1.04 trillion.

Market Cap	1.11T
Enterprise Value	1.04T

Important Dates

The next estimated earnings date is Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	Jul 16, 2024

Share Statistics

Dr. Reddy's Laboratories has 166.59 million shares outstanding. The number of shares has increased by 0.20% in one year.

Shares Outstanding	166.59M
Shares Change (YoY)	+0.20%
Shares Change (QoQ)	-0.02%
Owned by Insiders (%)	26.81%
Owned by Institutions (%)	51.67%
Float	119.88M

Valuation Ratios

The trailing PE ratio is 19.96 and the forward PE ratio is 18.99. Dr. Reddy's Laboratories's PEG ratio is 1.47.

PE Ratio	19.96
Forward PE	18.99
PS Ratio	3.84
PB Ratio	3.76
P/FCF Ratio	44.67
PEG Ratio	1.47

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.92, with an EV/FCF ratio of 42.09.

EV / Earnings	18.79
EV / Sales	3.62
EV / EBITDA	12.92
EV / EBIT	15.88
EV / FCF	42.09

Financial Position

The company has a current ratio of 2.55, with a Debt / Equity ratio of 10.41.

Current Ratio	2.55
Quick Ratio	1.66
Debt / Equity	10.41
Debt / EBITDA	0.38
Debt / FCF	1.24
Interest Coverage	33.85

Financial Efficiency

Return on equity (ROE) is 20.59% and return on invested capital (ROIC) is 14.06%.

Return on Equity (ROE)	20.59%
Return on Assets (ROA)	10.93%
Return on Capital (ROIC)	14.06%
Revenue Per Employee	10.67M
Profits Per Employee	2.05M
Employee Count	27,048
Asset Turnover	0.77
Inventory Turnover	1.95

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.43% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+18.43%
50-Day Moving Average	6,789.66
200-Day Moving Average	6,195.34
Relative Strength Index (RSI)	37.14
Average Volume (20 Days)	7,758

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr. Reddy's Laboratories had revenue of INR 288.51 billion and earned 55.58 billion in profits. Earnings per share was 333.26.

Revenue	288.51B
Gross Profit	170.40B
Operating Income	65.60B
Pretax Income	72.23B
Net Income	55.58B
EBITDA	79.54B
EBIT	65.60B
Earnings Per Share (EPS)	333.26

Full Income Statement

Balance Sheet

The company has 94.63 billion in cash and 30.68 billion in debt, giving a net cash position of 63.95 billion or 383.89 per share.

Cash & Cash Equivalents	94.63B
Total Debt	30.68B
Net Cash	63.95B
Net Cash Per Share	383.89
Equity (Book Value)	294.63B
Book Value Per Share	1,769.05
Working Capital	163.52B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 42.68 billion and capital expenditures -17.87 billion, giving a free cash flow of 24.81 billion.

Operating Cash Flow	42.68B
Capital Expenditures	-17.87B
Free Cash Flow	24.81B
FCF Per Share	148.90

Full Cash Flow Statement

Margins

Gross margin is 59.06%, with operating and profit margins of 22.74% and 19.26%.

Gross Margin	59.06%
Operating Margin	22.74%
Pretax Margin	25.04%
Profit Margin	19.26%
EBITDA Margin	27.57%
EBIT Margin	22.74%
FCF Margin	8.60%

Dividends & Yields

This stock pays an annual dividend of 40.00, which amounts to a dividend yield of 0.60%.

Dividend Per Share	40.00
Dividend Yield	0.60%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	11.96%
Buyback Yield	-0.20%
Shareholder Yield	0.40%
Earnings Yield	5.01%
FCF Yield	2.24%

Dividend Details

Stock Splits

The last stock split was on August 28, 2006. It was a forward split with a ratio of 2.

Last Split Date	Aug 28, 2006
Split Type	Forward
Split Ratio	2